Gooden MJ et al. implied that Gal-9 could have a Janus-like dual activity based on the cell type affected; it can inhibit immunity in autoimmune disease on the one side, and stimulate immunity in cancer and allergy on the other side [70]. Here, LGALS9 is linked to autoimmune disease.